Exhaustion of the CD8+ T Cell Compartment in Patients with Mutations in Phosphoinositide 3-Kinase Delta

Pathogenic gain-of-function mutations in the gene encoding phosphoinositide 3-kinase delta (PI3Kδ) cause activated PI3Kδ syndrome (APDS), a disease characterized by humoral immunodeficiency, lymphadenopathy, and an inability to control persistent viral infections including Epstein–Barr virus (EBV) and cytomegalovirus (CMV) infections. Understanding the mechanisms leading to impaired immune response is important to optimally treat APDS patients. Immunosenescence of CD8+ T cells was suggested to contribute to APDS pathogenesis. However, the constitutive activation of T cells in APDS may also result in T cell exhaustion. Therefore, we studied exhaustion of the CD8+ T cell compartment in APDS patients and compared them with healthy controls and HIV patients, as a control for exhaustion. The subset distribution of the T cell compartment of APDS patients was comparable with HIV patients with decreased naive CD4+ and CD8+ T cells and increased effector CD8+ T cells. Like in HIV+ patients, expression of activation markers and inhibitory receptors CD160, CD244, and programmed death receptor (PD)-1 on CD8+ T cells was increased in APDS patients, indicating exhaustion. EBV-specific CD8+ T cells from APDS patients exhibited an exhausted phenotype that resembled HIV-specific CD8+ T cells in terms of inhibitory receptor expression. Inhibition of PD-1 on EBV-specific CD8+ T cells from APDS patients enhanced in vitro proliferation and effector cytokine production. Based on these results, we conclude that total and EBV-specific CD8+ T cells from APDS patients are characterized by T cell exhaustion. Furthermore, PD-1 checkpoint inhibition may provide a possible therapeutic approach to support the immune system of APDS patients to control EBV and CMV.

• Publication year

  2018

• Venue

  Frontiers in Immunology

• Publication date

  2018-03-07

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3389/fimmu.2018.00446PMID 29563914PMCID 5845988
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A cohort study

  2018influential reference
• Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study

  2017cited by this paper
• Clinical Trial of the Anti-PD-L1 Antibody BMS-936559 in HIV-1 Infected Participants on Suppressive Antiretroviral Therapy

  2017cited by this paper
• Effective "activated PI3Kδ syndrome"-targeted therapy with the PI3Kδ inhibitor leniolisib.

  2017cited by this paper
• Mutations in the adaptor-binding domain and associated linker region of p110δ cause Activated PI3K-δ Syndrome 1 (APDS1)

  2017cited by this paper
• Genetic defects in PI3Kδ affect B-cell differentiation and maturation leading to hypogammaglobulineamia and recurrent infections.

  2017cited by this paper
• Combined nivolumab and ipilimumab versus ipilimumab alone in patients with advanced melanoma: 2-year overall survival outcomes in a multicentre, randomised, controlled, phase 2 trial.

  2016cited by this paper
• Ensembl 2017

  2016cited by this paper
• Phosphatidylinositol 3-Kinase p110δ Isoform Regulates CD8+ T Cell Responses during Acute Viral and Intracellular Bacterial Infections

  2016cited by this paper
• Clinical and immunologic phenotype associated with activated phosphoinositide 3-kinase δ syndrome 2: A cohort study.

  2016cited by this paper
• Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade

  2016cited by this paper
• Aging of mice is associated with p16(Ink4a)- and β-galactosidase-positive macrophage accumulation that can be induced in young mice by senescent cells

  2016cited by this paper
• Convergence of Innate and Adaptive Immunity during Human Aging

  2016cited by this paper
• Clinical and immunologic phenotype associated with activated ă phosphoinositide 3-kinase delta syndrome 2: A cohort study

  2016cited by this paper
• PI3Kδ and primary immunodeficiencies

  2016cited by this paper
• PI3Kδ Regulates the Magnitude of CD8+ T Cell Responses after Challenge with Listeria monocytogenes

  2015cited by this paper
• The future of immune checkpoint therapy

  2015cited by this paper
• Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.

  2015cited by this paper
• Molecular and cellular insights into T cell exhaustion

  2015cited by this paper
• Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.

  2015cited by this paper
• Heterozygous splice mutation in PIK3R1 causes human immunodeficiency with lymphoproliferation due to dominant activation of PI3K

  2014cited by this paper
• T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion

  2013cited by this paper
• A Randomized, Double-Blind, Placebo-Controlled Assessment of BMS-936558, a Fully Human Monoclonal Antibody to Programmed Death-1 (PD-1), in Patients with Chronic Hepatitis C Virus Infection

  2013cited by this paper
• Aging, cellular senescence, and cancer.

  2013cited by this paper
• Molecular mechanisms of T cell co-stimulation and co-inhibition

  2013cited by this paper
• Phosphoinositide 3-Kinase δ Gene Mutation Predisposes to Respiratory Infection and Airway Damage

  2013influential reference
• Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)

  2013cited by this paper
• Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency

  2013influential reference
• CD160 and PD-1 Co-Expression on HIV-Specific CD8 T Cells Defines a Subset with Advanced Dysfunction

  2012cited by this paper
• The blockade of immune checkpoints in cancer immunotherapy

  2012cited by this paper
• Progressive Loss of Memory T Cell Potential and Commitment to Exhaustion during Chronic Viral Infection

  2012cited by this paper
• Inhibitory Receptors on Lymphocytes: Insights from Infections

  2012cited by this paper
• T cell exhaustion

  2011cited by this paper
• Four faces of cellular senescence

  2011cited by this paper
• Are senescence and exhaustion intertwined or unrelated processes that compromise immunity?

  2011cited by this paper
• Chronic virus infection enforces demethylation of the locus that encodes PD-1 in antigen-specific CD8(+) T cells.

  2011cited by this paper
• Apoptosis and aging: increased resistance to apoptosis enhances the aging process

  2011cited by this paper
• Surface expression patterns of negative regulatory molecules identify determinants of virus-specific CD8+ T-cell exhaustion in HIV infection.

  2011cited by this paper
• The PI3K Isoforms p110α and p110δ Are Essential for Pre–B Cell Receptor Signaling and B Cell Development

  2010cited by this paper
• Phosphatidylinositol 3-Kinase (PI3K) Signaling via Glycogen Synthase Kinase-3 (Gsk-3) Regulates DNA Methylation of Imprinted Loci*

  2010cited by this paper
• Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates.

  2010cited by this paper
• The emerging mechanisms of isoform-specific PI3K signalling

  2010cited by this paper
• The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus‐specific CD8+ T‐cell function

  2010cited by this paper
• Features of responding T cells in cancer and chronic infection.

  2010cited by this paper
• The PD‐1 pathway in tolerance and autoimmunity

  2010cited by this paper
• Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection

  2009cited by this paper
• Chronic Antigen Stimulation Alone Is Sufficient to Drive CD8+ T Cell Exhaustion1

  2009cited by this paper
• PI3 kinase signals BCR-dependent mature B cell survival.

  2009cited by this paper
• Differential Association of Programmed Death-1 and CD57 with Ex Vivo Survival of CD8+ T Cells in HIV Infection1

  2009cited by this paper
• Enhancing SIV-Specific Immunity In Vivo by PD-1 Blockade

  2008cited by this paper
• Cellular senescence: when bad things happen to good cells

  2007cited by this paper
• Cytomegalovirus Infection

  2007cited by this paper
• Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection.

  2007cited by this paper
• Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection

  2007cited by this paper
• Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 Expression

  2006cited by this paper
• The PD-1-PD-L pathway in immunological tolerance.

  2006cited by this paper
• Identification of variations in the human phosphoinositide 3‐kinase p110δ gene in children with primary B‐cell immunodeficiency of unknown aetiology

  2006cited by this paper
• PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection

  2006cited by this paper
• Tissue expression of PD-L1 mediates peripheral T cell tolerance

  2006cited by this paper
• Restoring function in exhausted CD8 T cells during chronic viral infection

  2006cited by this paper
• PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression

  2006cited by this paper
• Corrigendum: Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

  2006cited by this paper
• Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

  2006cited by this paper
• Immunosenescence: a problem of lymphopoiesis, homeostasis, microenvironment, and signaling

  2005cited by this paper
• CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms

  2004cited by this paper
• Survival

  2004cited by this paper
• PI3K in lymphocyte development, differentiation and activation

  2003cited by this paper
• Ablation of CD8 and CD4 T Cell Responses by High Viral Loads1

  2003cited by this paper
• Viral Persistence Alters CD8 T-Cell Immunodominance and Tissue Distribution and Results in Distinct Stages of Functional Impairment

  2003cited by this paper
• Impaired B and T Cell Antigen Receptor Signaling in p110δ PI 3-Kinase Mutant Mice

  2002cited by this paper
• Increased CD95/Fas-induced apoptosis of HIV-specific CD8(+) T cells.

  2001cited by this paper
• PI3K-signalling in B- and T-cells: insights from gene-targeted mice.

  2001cited by this paper
• A Significant Number of Human Immunodeficiency Virus Epitope-Specific Cytotoxic T Lymphocytes Detected by Tetramer Binding Do Not Produce Gamma Interferon

  2000cited by this paper
• Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection.

  2000cited by this paper
• Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

  1999cited by this paper
• Resistance to apoptosis in human CD 8 1 T cells that reach replicative senescence after multiple rounds of antigen-specific proliferation <

  1999cited by this paper
• Structure and function of phosphoinositide 3-kinases.

  1998cited by this paper
• Induction and Exhaustion of Lymphocytic Choriomeningitis Virus–specific Cytotoxic T Lymphocytes Visualized Using Soluble Tetrameric Major Histocompatibility Complex Class I–Peptide Complexes

  1998cited by this paper
• Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function

  1998cited by this paper
• p110δ, a novel phosphoinositide 3-kinase in leukocytes

  1997cited by this paper
• P110delta, a novel phosphoinositide 3-kinase in leukocytes.

  1997cited by this paper
• The Aging Immune System: Primer and Prospectus

  1996cited by this paper
• Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

  1993cited by this paper
• Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells

  1993cited by this paper
• T-cell subset alterations in HIV-infected homosexual men: NIAID Multicenter AIDS cohort study.

  1989cited by this paper

• 朗格汉斯细胞组织细胞增生症的免疫微环境：从免疫抑制到靶向治疗

  2025cites this paper
• From infection to immune exhaustion: The Epstein-Barr virus and its contribution to Immunosenescence.

  2025cites this paper
• Inborn errors of immunity presenting with lymphoproliferation: lessons from a case series

  2025cites this paper
• Scalable generation and functional classification of genetic variants in inborn errors of immunity to accelerate clinical diagnosis and treatment.

  2025cites this paper
• A survey of diagnosis and therapy of inborn errors of immunity among practice-based physicians and clinic-based pneumologists and hemato-oncologists

  2025cites this paper
• The Role and Research Progress of CD8+ T Cells in Sepsis

  2025cites this paper
• Senescent B cells regulate CD38 expression via FOXO1 in pneumonia resulting from PIK3CD (R437C) mutations

  2025cites this paper
• PI3K GOF leads to dysregulation of T and B cells that both contribute to extrinsically driving activation and differentiation of other CD4 + T cells

  2025cites this paper
• Hyperactivation of the PI3K pathway in inborn errors of immunity: current understanding and therapeutic perspectives

  2024cites this paper
• Both T and B cells contribute to dysregulated activation and differentiation of CD4+ T cells in Activated PI3K delta syndrome 1

  2024cites this paper
• Clinical implications of hepatitis B virus core antigen‐mediated immunopathologic T cell responses in chronic hepatitis B

  2024cites this paper
• Technical challenges of intracellular flow cytometry-based assays as a functional complement to diagnosis of signaling defects of inborn errors of immunity: PI3K pathway as a case of study

  2024cites this paper
• Activated PI3Kδ syndrome – reviewing challenges in diagnosis and treatment

  2023influential citation
• Early Triple-Negative Breast Cancers in a Singapore Cohort Exhibit High PIK3CA Mutation Rates Associated With Low PD-L1 Expression.

  2023cites this paper
• ANCA vasculitis expands the spectrum of autoimmune manifestations of activated PI3 kinase δ syndrome

  2023cites this paper
• Modulating the PI3K Signalling Pathway in Activated PI3K Delta Syndrome: a Clinical Perspective

  2023cites this paper
• Future Directions in the Diagnosis and Treatment of APDS and IEI: a Survey of German IEI Centers

  2023cites this paper
• Human PIK3R1 mutations disrupt lymphocyte differentiation to cause activated PI3Kδ syndrome 2

  2023cites this paper
• AKT Hyperphosphorylation and T Cell Exhaustion in Down Syndrome

  2022cites this paper
• Defining and targeting patterns of T cell dysfunction in inborn errors of immunity

  2022influential citation
• Case Report: EBV Chronic Infection and Lymphoproliferation in Four APDS Patients: The Challenge of Proper Characterization, Therapy, and Follow-Up

  2021cites this paper
• Genetic screening of children with marrow failure. The role of primary Immunodeficiencies

  2021cites this paper
• Hemophagocytic Lymphohistiocytosis in Activated PI3K Delta Syndrome: an Illustrative Case Report

  2021cites this paper
• Phosphatidylinositol 3-kinase signaling and immune regulation: insights into disease pathogenesis and clinical implications

  2021influential citation
• Activated PI3Kinase Delta Syndrome—A Multifaceted Disease

  2021cites this paper
• Natural Course of Activated Phosphoinositide 3-Kinase Delta Syndrome in Childhood and Adolescence

  2021cites this paper
• Clinical Manifestations and Outcomes of Activated Phosphoinositide 3-Kinase δ Syndrome from the USIDNET Cohort.

  2021cites this paper
• Accelerated Maturation, Exhaustion, and Senescence of T cells in 22q11.2 Deletion Syndrome

  2021cites this paper
• Genetic susceptibility to EBV infection: insights from inborn errors of immunity

  2020influential citation
• Application of Cytometry in Primary Immunodeficiencies

  2020cites this paper
• Hyperactive PI3Kδ predisposes naive T cells to activation via aerobic glycolysis programs

  2020cites this paper
• Counteracting CAR T cell dysfunction

  2020cites this paper
• Activated Phosphoinositide 3-Kinase Delta Syndrome 1: Clinical and Immunological Data from an Italian Cohort of Patients

  2020cites this paper
• Evaluation of B‐cell intracellular signaling by monitoring the PI3K‐Akt axis in patients with common variable immunodeficiency and activated phosphoinositide 3‐kinase delta syndrome

  2020cites this paper
• Immunophenotyping of A20 haploinsufficiency by multicolor flow cytometry.

  2020cites this paper
• Activating mutations in PIK3CD and murine CD4 + T cells

  2019cites this paper
• Phenotypical T Cell Differentiation Analysis: A Diagnostic and Predictive Tool in the Study of Primary Immunodeficiencies

  2019cites this paper
• T and B‐cell signaling in activated PI3K delta syndrome: From immunodeficiency to autoimmunity

  2019cites this paper
• Case Study: Mechanism for Increased Follicular Helper T Cell Development in Activated PI3K Delta Syndrome

  2019cites this paper
• Immune Dysregulation and Disease Pathogenesis due to Activating Mutations in PIK3CD—the Goldilocks’ Effect

  2019cites this paper
• Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4+ T cells.

  2019cites this paper
• Activated PI3Kδ breaches multiple B cell tolerance checkpoints and causes autoantibody production

  2019cites this paper
• CD57 identifies T cells with functional senescence before terminal differentiation and relative telomere shortening in patients with activated PI3 kinase delta syndrome

  2018cites this paper
• Class-Switch Recombination (CSR)/Hyper-IgM (HIGM) Syndromes and Phosphoinositide 3-Kinase (PI3K) Defects

  2018cites this paper
• Genetic Defects in Phosphoinositide 3-Kinase δ Influence CD8+ T Cell Survival, Differentiation, and Function

  2018cites this paper
• Multivariate Computational Analysis of Gamma Delta T Cell Inhibitory Receptor Signatures Reveals the Divergence of Healthy and ART-Suppressed HIV+ Aging

  2018cites this paper
• CD4 T cells control development and maintenance of brain-resident CD8 T cells during polyomavirus infection

  2018cites this paper